Considering sorafenib’s effect on morphological remodeling of mitochondria, loss of Rb probably acted to increase mitochondrial ROS to promote the cytotoxic effect of sorafenib on HCC cells (Louandre et al., 2015). This evidence concerns the gene RB1 and hepatocellular carcinoma.